SCHEMBL533852

SCHEMBL533852

CC(=O)C#Cc1c(Cl)cccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
NOTUM Q6P988 5/20 0.37
ATM Q13315 1/20 0.37
TSHR P16473 2/20 0.36
AKR1B1 P15121 1/20 0.36
FEN1 P39748 2/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
LMNA P02545 3/20 0.34
POLB P06746 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
BLM P54132 1/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ERCC5 P28715 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6577018 0.81 TSHR (0.42) ALDH1A1NOTUMTSHRAKR1B1FEN1
SCHEMBL12430909 0.78 PTGDR2 (0.46) ALDH1A1CES2CES1POLB
SCHEMBL12168758 0.74 ALDH1A1 (0.45) ALDH1A1TSHRLMNACYP1A2CYP2D6
SCHEMBL8185797 0.71 KCNH2 (0.50) CYP2D6
SCHEMBL2459837 0.70 CYP1A2 (0.39) ALDH1A1TSHRLMNACYP1A2CYP2D6
SCHEMBL16803398 0.70 NPSR1 (0.44) ALDH1A1NPSR1KMT2AMAPT
SCHEMBL4487823 0.68 ACACB (0.46) ALDH1A1TSHRCES2CES1LMNA
SCHEMBL31337628 0.68 PYGL (0.57) TSHRNPSR1KMT2A
SCHEMBL26664834 0.68 PYGL (0.57) TSHRNPSR1KMT2A
Acetone SCHEMBL28013960 0.67 TSHR (0.56) ALDH1A1NOTUMTSHRAKR1B1FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035214-A1 RENIN INHIBITORS MERCK CANADA INC. (CA) 2012-02-09 US disclosed
EP-2413941-A1 RENIN INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-02-08 EP disclosed
WO-2010114978-A1 RENIN INHIBITORS MERCK SHARP & DOHME CORP. (US) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035214-A1 RENIN INHIBITORS REN, ACE, AGTR1 ALDH1A1 900/4885NOTUM 1301/4885ATM 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.